JAZZ Jazz Pharmaceuticals plc - Ordinary Shares
$252,44
Prezzo · Ago 18, 2026
Fondamentali al Ago 3, 2026
Intervallo 52 sett.
$118–$265
91% of range
Rating Analisti
BUY
26 analysts
Prezzo Obiettivo
$281
+11% upside
P/E (TTM)
-29.1
ROE
—
Margine di Profitto Netto
—
Informazioni su Jazz Pharmaceuticals plc - Ordinary Shares Panoramica della società da Wikipedia
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Leggi di più
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Company history and acquisitions
2010–2019
On 18 February 2010, the FDA accepted a new drug application for JZP-6 (Sodium oxybate) for the treatment of Fibromyalgia. In the following December, a new patent was issued for Sodium Oxybate.
On September 19, 2011, Jazz Pharmaceuticals merged with Irish Azur Pharma plc to form Jazz Pharmaceuticals plc. The Azur Pharma seat in Dublin became the headquarters of the combined company. Azur Pharma had been marketing specialty pharmaceutical products in the central nervous system (CNS) and women's health areas with US operations in Philadelphia.
On 26 April 2012, the company acquired EUSA Pharma for $650 million (plus $50 million in milestone payments). In September, the company sold its Women's Health business to Meda for $95 million. In December, the company began clinical trial of intravenous Erwinaze in patients with Acute Lymphoblastic Leukemia.
In January 2014, the company announced it would acquire the rare disease drug developer Gentium SpA and its lead product Defitelio for $1 billion.
In May 2016, the company announced it would acquire Alizé Pharma II for $20.5 million. At the end of the same month, the company announced its then largest acquisition, with the purchase of Celator Pharmaceuticals for $1.5 billion. As a result, Jazz obtained the rights to breakthrough therapy Vyxeos (liposomal daunorubicin and cytarabine) for treatment of acute myeloid leukemia.
In August 2019, the company announced it would acquire Cavion Inc. for up to $310 million.
2020–present
In January 2021, Jazz announced it would acquire cannabis-focused medicinal drug company GW Pharmaceuticals for US$7.2 billion. This acquisition added the medication Epidiolex (cannabidiol), developed to treat severe epilepsy syndromes, to the company's portfolio.
In November 2025, Jazz Pharmaceuticals announced positive results from its Phase 3 trial for its cancer drug, Ziihera, a potential treatment for advanced gastroesophageal cancer.
Acquisition history
The following is an illustration of the company's mergers, acquisitions, spin-offs and historical predecessors:
== References ==
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
JAZZ Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$252.44
Capitalizzazione di Mercato
—
P/E (TTM)
-29.1
EPS (TTM)
$-5.84
Ricavi (TTM)
$4.27B
Rendimento div.
—
ROE
—
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$118 – $265
JAZZ Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$4.27B
2016-12-31
→
2025-12-31
EPS
$-5.84
2016-12-31
→
2025-12-31
Flusso di cassa libero
—
Margini
—
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
JAZZ
Mediana dei peer
P/E (TTM)
-29.1
530.6
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
JAZZ
Mediana dei peer
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
JAZZ
Mediana dei peer
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
JAZZ
Mediana dei peer
Revenue YoY (Ricavi YoY)
4.9%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
5.3%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
12.5%
—
EPS YoY
41.8%
—
Net Income YoY (Utile Netto YoY)
35.0%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
JAZZ
Mediana dei peer
JAZZ Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
26 analisti
- Acquisto forte 7 26,9%
- Compra 17 65,4%
- Mantieni 2 7,7%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
20 analisti · 2026-08-15
Mediana
$285.00
Ora
$252.44
Basso
$196.00
Alto
$315.00
Target mediano
$285.00
+12,9%
Target medio
$281.10
+11,4%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.06%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $5.71 | $6.30 | -0.59% |
| 31 Marzo 2026 | $6.34 | $4.66 | 1.7% |
| 31 Dicembre 2025 | $6.64 | $6.65 | -0.01% |
| 30 Settembre 2025 | $8.13 | $6.04 | 2.1% |
| 30 Giugno 2025 | $-8.25 | $-7.76 | -0.49% |
| 31 Marzo 2025 | $1.68 | $4.75 | -3.1% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| JAZZ | — | -29.1 | 4.9% | — | — | — |
| GHRS | — | — | — | — | — | — |
| PRGO | $1.92B | -1.4 | -2.8% | -33.5% | -38.5% | 35.1% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| R&D Expense | · | · | · | · | · | · | $300M | $227M | $198M | $162M | $135M | $85M | |
| SG&A Expense | $1.81B | $1.39B | $1.34B | $1.42B | $1.45B | $854M | $737M | $684M | $544M | $503M | $449M | $406M | |
| Operating Expenses | $4.70B | $3.35B | $3.26B | $3.72B | $2.92B | $1.99B | $1.63B | $1.28B | $1.09B | $896M | $817M | $977M | |
| Operating Income | $-430M | $717M | $579M | $-66M | $170M | $378M | $532M | $615M | $529M | $592M | $508M | $196M | |
| Interest Income | $86M | $106M | $65M | $12M | $2M | $11M | $20M | $17M | $4M | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $1M | $9M | |
| Pretax Income | $-628M | $470M | $298M | $-373M | $-113M | $275M | $454M | $529M | $441M | $532M | $436M | $152M | |
| Income Tax | $-272M | $-91M | $-120M | $-159M | $216M | $34M | $-73M | $80M | $-48M | $135M | $106M | $94M | |
| Net Income | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| EPS (Basic) | $-5.84 | $9.06 | $6.55 | $-3.58 | $-5.52 | $4.28 | $9.22 | $7.45 | $8.13 | $6.56 | $5.38 | $0.98 | |
| EPS (Diluted) | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 | $4.22 | $9.09 | $7.30 | $7.96 | $6.41 | $5.23 | $0.93 | |
| Shares (Basic) | 60,981,000 | 61,838,000 | 63,291,000 | 62,539,000 | 59,694,000 | 55,712,000 | 56,749,000 | 59,976,000 | 60,018,000 | 60,500,000 | 61,232,000 | 59,746,000 | |
| Shares (Diluted) | 60,981,000 | 66,007,000 | 72,066,000 | 62,539,000 | 59,694,000 | 56,517,000 | 57,550,000 | 61,221,000 | 61,317,000 | 61,870,000 | 63,036,000 | 62,614,000 |
Stato Patrimoniale 26
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.39B | $2.41B | $1.51B | $881M | $591M | $1.06B | $637M | $310M | $386M | $366M | $989M | $684M | |
| Receivables | $831M | $717M | $706M | $651M | $563M | $396M | $356M | $264M | $224M | $234M | $210M | $186M | |
| Inventory | $417M | $480M | $597M | $714M | $1.07B | $95M | $79M | $53M | $43M | $34M | $19M | $30M | |
| Prepaid Expense | $152M | $177M | $185M | $92M | $131M | $62M | $39M | $25M | $23M | $25M | $21M | $13M | |
| Other Current Assets | $324M | $262M | $321M | $267M | $252M | $152M | $79M | $68M | $77M | $29M | $19M | $21M | |
| Current Assets | $4.17B | $4.63B | $3.44B | $2.61B | $2.61B | $2.84B | $1.63B | $1.23B | $968M | $748M | $1.26B | $1.02B | |
| PP&E (Net) | · | · | · | · | · | $128M | $132M | $200M | $170M | $107M | $86M | $58M | |
| PP&E (Gross) | · | · | · | · | · | $196M | $187M | $250M | $211M | $140M | $109M | $74M | |
| Accum. Depreciation | · | · | · | · | · | $68M | $55M | $50M | $41M | $32M | $24M | $15M | |
| Goodwill | $1.83B | $1.72B | $1.75B | $1.69B | $1.83B | $958M | $920M | $928M | $948M | $894M | $657M | $703M | |
| Intangibles | $4.43B | $4.76B | $5.42B | $5.79B | $7.15B | $2.20B | $2.44B | $2.73B | $2.98B | $3.01B | $1.19B | $1.44B | |
| Other Non-current Assets | $99M | $114M | $67M | $55M | $41M | $26M | $48M | $43M | $16M | $14M | $9M | $16M | |
| Total Assets | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Accounts Payable | $122M | $78M | $103M | $91M | $100M | $27M | $46M | $41M | $24M | $22M | $22M | $25M | |
| Accrued Liabilities | $1.03B | $911M | $794M | $803M | $666M | $353M | $270M | $265M | $199M | $193M | $164M | $164M | |
| Current Liabilities | $2.24B | $1.04B | $1.54B | $933M | $809M | $654M | $364M | $345M | $294M | $257M | $227M | $217M | |
| Capital Leases | $51M | $39M | $59M | $72M | $87M | $140M | $151M | $0 | · | · | · | · | |
| Deferred Tax | $594M | $677M | $848M | $944M | $1.30B | $130M | $224M | $309M | $383M | $557M | $283M | $375M | |
| Other Non-current Liabilities | $124M | $87M | $105M | $107M | $117M | $101M | $109M | $219M | $177M | $113M | $69M | $38M | |
| Long-term Debt | $5.36B | $6.11B | $5.71B | $5.72B | $6.05B | $2.09B | $1.61B | $1.60B | $1.58B | $2.03B | $1.19B | $1.34B | |
| Common Stock | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Retained Earnings | $646M | $1.13B | $879M | $734M | $830M | $1.16B | $1.07B | $841M | $918M | $529M | $303M | $35M | |
| AOCI | $-569M | $-948M | $-842M | $-1.13B | $-400M | $-134M | $-223M | $-198M | $-141M | $-317M | $-267M | $-122M | |
| Stockholders' Equity | $4.32B | $4.09B | $3.74B | $3.09B | $3.97B | $3.66B | $3.11B | $2.76B | $2.71B | $1.88B | $1.71B | $1.37B | |
| Liabilities + Equity | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Shares Outstanding | 61,400,000 | 60,600,000 | 62,255,000 | 63,214,000 | 61,633,000 | 56,171,000 | 56,140,000 | 57,704,000 | 58,898,000 | 59,820,000 | 61,305,000 | 60,643,000 |
Flusso di cassa 12
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $33M | $30M | $30M | $27M | $19M | $15M | $15M | $13M | $12M | $10M | · | |
| Stock-based Comp | $291M | $248M | $227M | $222M | $189M | $121M | $111M | $102M | $107M | $99M | $92M | $70M | |
| Deferred Tax | $-445M | $-208M | $-260M | $-292M | $69M | $-137M | $-237M | $-89M | $-226M | $-41M | $-68M | $-49M | |
| Amort. of Intangibles | $655M | $627M | $608M | $599M | $526M | $260M | $355M | $201M | $152M | $102M | $98M | $127M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Operating Cash Flow | $1.36B | $1.40B | $1.09B | $1.27B | $779M | $900M | $776M | $799M | $693M | $592M | $532M | $408M | |
| CapEx | $59M | $38M | $24M | $29M | $28M | $15M | $40M | $20M | $29M | $10M | $36M | $36M | |
| Investing Cash Flow | $-1.51B | $-508M | $-163M | $-446M | $-5.21B | $-1.01B | $-155M | $-394M | $-269M | $-1.75B | $-2M | $-1.07B | |
| Stock Repurchased | $125M | $311M | $270M | $54.0K | $0 | $147M | $301M | $524M | $99M | $278M | $62M | $42M | |
| Financing Cash Flow | $-873M | $21M | $-305M | $-529M | $3.97B | $528M | $-294M | $-479M | $-409M | $541M | $-214M | $711M | |
| Net Change in Cash | $-1.02B | $907M | $625M | $290M | $-466M | $420M | $328M | $-76M | $20M | $-623M | $305M | $48M | |
| Taxes Paid | $122M | $115M | $178M | · | · | · | · | · | · | · | · | · |
Tassi di Crescita 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.9% | 6.1% | 4.8% | 18.3% | 30.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.3% | 9.6% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 12.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 41.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | 13.1% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 35.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | 20.2% | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| Net Income TTM | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| P/E | -29.1 | 14.2 | 20.2 | -44.5 | -23.1 | 39.1 | 16.4 | 17.0 | 16.9 | 17.0 | 26.9 | 176.1 | |
| P / Tangible Book | · | · | · | · | · | 18.3 | · | · | · | · | · | · | |
| Earnings Yield | -3.4% | 7.0% | 5.0% | -2.2% | -4.3% | 2.6% | 6.1% | 5.9% | 5.9% | 5.9% | 3.7% | 0.57% |
Conto Economico 13
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.07B | $1.20B | $1.13B | $1.05B | $898M | $1.09B | $1.05B | $1.02B | $902M | $1.01B | $972M | $957M | $893M | $972M | $941M | |
| SG&A Expense | $389M | $353M | $406M | $531M | $358M | $514M | $369M | $326M | $339M | $352M | $396M | $308M | $341M | $298M | $383M | $358M | |
| Operating Expenses | $960M | $732M | $943M | $1.07B | $1.73B | $954M | $897M | $795M | $824M | $836M | $889M | $800M | $800M | $767M | $1.24B | $916M | |
| Operating Income | $248M | $337M | $255M | $58M | $-686M | $-56M | $191M | $260M | $199M | $66M | $122M | $172M | $158M | $126M | $-263M | $25M | |
| Interest Income | $25M | $23M | $20M | $19M | $19M | $28M | $32M | $26M | $25M | $23M | $21M | $19M | $15M | $11M | $7M | $4M | |
| Pretax Income | $211M | $299M | $208M | $9M | $-736M | $-110M | $133M | $201M | $138M | $-2M | $62M | $100M | $82M | $55M | $-340M | $-60M | |
| Income Tax | $18M | $6M | $5M | $-242M | $-17M | $-18M | $-58M | $-15M | $-31M | $12M | $-33M | $-47M | $-24M | $-15M | $-100M | $-43M | |
| Net Income | $193M | $293M | $203M | $251M | $-718M | $-92M | $191M | $215M | $169M | $-15M | $94M | $147M | $104M | $69M | $-241M | $-20M | |
| EPS (Basic) | $3.05 | $4.73 | $3.28 | $4.14 | $-11.74 | $-1.52 | $3.11 | $3.50 | $2.68 | $-0.23 | $1.50 | $2.33 | $1.63 | $1.09 | $-3.86 | $-0.31 | |
| EPS (Diluted) | $2.78 | $4.43 | $3.34 | $4.08 | $-11.74 | $-1.52 | $2.97 | $3.42 | $2.49 | $-0.23 | $1.40 | $2.14 | $1.52 | $1.04 | $-3.85 | $-0.31 | |
| Shares (Basic) | 63,200,000 | 61,900,000 | -121,888,000 | 60,696,000 | 61,200,000 | 61,000,000 | -124,995,000 | 61,414,000 | 62,882,000 | 62,537,000 | -127,308,000 | 63,114,000 | 63,991,000 | 63,494,000 | -124,547,000 | 62,785,000 | |
| Shares (Diluted) | 69,400,000 | 66,100,000 | -122,798,000 | 61,606,000 | 61,200,000 | 61,000,000 | -129,329,000 | 63,174,000 | 69,625,000 | 62,537,000 | -146,538,000 | 71,293,000 | 73,540,000 | 73,771,000 | -126,584,000 | 62,785,000 | |
| EBITDA | $248M | $337M | · | $58M | $-686M | $-56M | · | $260M | $199M | $66M | · | $172M | $158M | $126M | · | $25M |
Stato Patrimoniale 24
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.62B | $1.84B | $1.39B | $1.33B | $1.19B | $1.86B | $2.41B | $2.22B | $1.36B | $1.44B | · | $1.34B | $1.28B | $1.17B | · | $839M | |
| Receivables | $881M | $836M | $831M | $764M | $714M | $653M | $717M | $724M | $698M | $707M | · | $628M | $610M | $624M | · | $601M | |
| Inventory | $443M | $438M | $417M | $483M | $505M | $493M | $480M | $539M | $543M | $577M | · | $612M | $657M | $675M | · | $728M | |
| Prepaid Expense | $200M | $150M | $152M | $147M | $164M | $150M | $177M | $155M | $134M | $123M | · | $110M | $107M | $73M | · | $93M | |
| Other Current Assets | $244M | $285M | $324M | $315M | $298M | $260M | $262M | $354M | $326M | $315M | · | $310M | $272M | $245M | · | $250M | |
| Current Assets | $3.97B | $4.58B | $4.17B | $3.76B | $3.35B | $4.13B | $4.63B | $4.39B | $3.68B | $3.54B | · | $3.25B | $3.01B | $2.78B | · | $2.57B | |
| Goodwill | $1.80B | $1.80B | $1.83B | $1.83B | $1.84B | $1.76B | $1.72B | $1.80B | $1.74B | $1.74B | · | $1.71B | $1.74B | $1.72B | · | $1.59B | |
| Intangibles | $4.03B | $4.20B | $4.43B | $4.57B | $4.77B | $4.72B | $4.76B | $5.14B | $5.08B | $5.24B | · | $5.42B | $5.71B | $5.76B | · | $5.57B | |
| Other Non-current Assets | $86M | $95M | $99M | $103M | $121M | $117M | $114M | $75M | $71M | $71M | · | $76M | $66M | $64M | · | $35M | |
| Total Assets | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Accounts Payable | $128M | $100M | $122M | $152M | $89M | $96M | $78M | $85M | $97M | $81M | · | $110M | $98M | $125M | · | $102M | |
| Accrued Liabilities | $1.03B | $1.02B | $1.03B | $1.00B | $875M | $1.06B | $911M | $859M | $801M | $827M | · | $770M | $748M | $712M | · | $668M | |
| Current Liabilities | $2.23B | $2.25B | $2.24B | $2.27B | $2.07B | $1.22B | $1.04B | $1.03B | $1.56B | $1.56B | · | $1.57B | $945M | $909M | · | $813M | |
| Capital Leases | $44M | $47M | $51M | $53M | $55M | $39M | $39M | $71M | $68M | $56M | · | $62M | $66M | $72M | · | $73M | |
| Deferred Tax | $529M | $548M | $594M | $629M | $682M | $671M | $677M | $792M | $775M | $810M | · | $841M | $911M | $932M | · | $934M | |
| Other Non-current Liabilities | $141M | $162M | $125M | $109M | $94M | $91M | $87M | $111M | $99M | $97M | · | $127M | $127M | $109M | · | $124M | |
| Long-term Debt | $4.35B | $5.35B | $5.36B | $5.36B | $5.36B | $5.37B | $6.11B | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Total Debt | $4.35B | $5.35B | · | $5.36B | $5.36B | $5.37B | · | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Common Stock | $0 | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $1.13B | $939M | $646M | $443M | $191M | $1.03B | $1.13B | $936M | $871M | $864M | · | $884M | $812M | $803M | · | $974M | |
| AOCI | $-662M | $-651M | $-569M | $-570M | $-486M | $-786M | $-948M | $-603M | $-888M | $-882M | · | $-1.04B | $-867M | $-980M | · | $-1.62B | |
| Stockholders' Equity | $4.80B | $4.53B | $4.32B | $3.96B | $3.71B | $4.17B | $4.09B | $4.17B | $3.76B | $3.70B | $3.74B | $3.49B | $3.53B | $3.34B | $3.09B | $2.75B | |
| Liabilities + Equity | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Shares Outstanding | 64,800,000 | 62,700,000 | 61,435,000 | 60,740,000 | 60,640,000 | 61,623,000 | 60,631,000 | 60,443,000 | 61,745,000 | 63,028,000 | 62,255,000 | 62,945,000 | · | · | 63,214,000 | · |
Flusso di cassa 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $73M | $74M | $71M | $88M | $65M | $68M | $70M | $60M | $57M | $61M | $53M | $56M | $61M | $56M | $62M | $57M | |
| Deferred Tax | $-39M | $-66M | $-63M | $-271M | $-66M | $-44M | $-2M | $-64M | $-75M | $-66M | $-36M | $-79M | $-79M | $-66M | $-145M | $-65M | |
| Amort. of Intangibles | $170M | $172M | $170M | $168M | $162M | $154M | $159M | $157M | $155M | $156M | $152M | $155M | $152M | $150M | $137M | $141M | |
| Operating Cash Flow | $416M | $408M | $363M | $475M | $89M | $430M | $399M | $399M | $331M | $267M | $167M | $307M | $297M | $321M | $342M | $418M | |
| CapEx | $18M | $20M | $17M | $15M | $13M | $14M | $13M | $11M | $7M | $7M | $10M | $4M | $6M | $4M | $9M | $-5M | |
| Investing Cash Flow | $355M | $123M | $-372M | $-328M | $-641M | $-169M | $-193M | $214M | $-257M | $-272M | $102M | $-174M | $-86M | $-5M | $-324M | $5M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $150M | · | · | $100M | $74M | · | · | $0 | $0 | |
| Financing Cash Flow | $-994M | $-78M | $75M | $-11M | $-125M | $-814M | $-8M | $246M | $-161M | $-57M | $-100M | $-78M | $-97M | $-30M | $20M | $-289M | |
| Net Change in Cash | $-224M | $452M | $66M | $136M | $-672M | $-551M | $195M | $862M | $-88M | $-63M | $171M | $53M | $114M | $286M | $42M | $128M | |
| Free Cash Flow | · | $388M | · | · | · | $416M | · | · | · | $260M | · | · | · | $317M | · | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| Net Margin | 16.0% | 27.4% | · | 22.3% | -68.7% | -10.3% | · | 20.4% | 16.5% | -1.6% | · | 15.1% | 10.9% | 7.8% | · | -2.1% | |
| Pretax Margin | 17.5% | 28.0% | · | 0.80% | -70.3% | -12.2% | · | 19.0% | 13.5% | -0.18% | · | 10.2% | 8.5% | 6.2% | · | -6.4% | |
| EBITDA Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| ROA | 1.8% | 2.5% | · | 2.1% | -6.4% | -0.81% | · | 1.8% | 1.5% | -0.13% | · | 1.4% | 0.93% | 0.61% | · | -0.17% | |
| ROE | 4.5% | 6.7% | · | 6.2% | -19.2% | -2.4% | · | 5.6% | 4.6% | -0.42% | · | 4.7% | 3.1% | 2.0% | · | -0.59% | |
| ROIC | 2.5% | 3.3% | · | 17.2% | -7.4% | -0.49% | · | 2.7% | 2.6% | 5.8% | · | 2.8% | 2.2% | 1.8% | · | 0.08% |
Liquidità e Solvibilità 4
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 2.0 | · | 1.7 | 1.6 | 3.4 | · | 4.3 | 2.4 | 2.3 | · | 2.1 | 3.2 | 3.1 | · | 3.2 | |
| Quick Ratio | 1.1 | 1.2 | · | 0.9 | 0.9 | 2.1 | · | 2.9 | 1.3 | 1.4 | · | 1.2 | 2.0 | 2.0 | · | 1.8 | |
| Debt / Equity | 0.9 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.7 | · | 2.1 | |
| LT Debt / Equity | 0.7 | 1.0 | · | 1.1 | 1.2 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 2.1 |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.3 | · | 1.6 | 1.6 | 1.4 | · | 1.6 | 1.6 | 1.5 | · | 1.7 |
Valutazione (TTM) 13
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.45B | $4.14B | · | $4.12B | $4.02B | $3.88B | · | $3.95B | $3.86B | $3.72B | · | $3.76B | $3.72B | $3.58B | · | $3.53B | |
| Net Income TTM | $19M | $-266M | · | $-345M | $-427M | $276M | · | $516M | $405M | $306M | · | $301M | $189M | $86M | · | $-36M | |
| Market Cap | $15.61B | $11.85B | · | $8.01B | $6.44B | $7.65B | · | $6.73B | $6.59B | $7.59B | · | $8.15B | · | · | · | · | |
| Enterprise Value | $18.35B | $15.36B | · | $12.04B | $10.61B | $11.16B | · | $10.63B | $10.94B | $11.86B | · | $12.53B | · | · | · | · | |
| P/E | -535.5 | -39.8 | · | -22.9 | -14.4 | 29.8 | · | 14.2 | 18.0 | 26.9 | · | 29.5 | 44.3 | 111.7 | · | -225.9 | |
| P/S | 3.5 | 2.9 | · | 1.9 | 1.6 | 2.0 | · | 1.7 | 1.7 | 2.0 | · | 2.2 | · | · | · | · | |
| P/B | 3.3 | 2.6 | · | 2.0 | 1.7 | 1.8 | · | 1.6 | 1.8 | 2.1 | · | 2.3 | · | · | · | · | |
| P / Cash Flow | · | 29.0 | · | · | · | 17.8 | · | · | · | 28.4 | · | · | · | · | · | · | |
| P / FCF | · | 30.5 | · | · | · | 18.4 | · | · | · | 29.2 | · | · | · | · | · | · | |
| EV / EBITDA | 73.9 | 45.6 | · | 209.4 | -15.5 | -199.6 | · | 40.8 | 54.9 | 179.1 | · | 72.7 | · | · | · | · | |
| EV / FCF | · | 39.5 | · | · | · | 26.8 | · | · | · | 45.5 | · | · | · | · | · | · | |
| EV / Revenue | 4.1 | 3.7 | · | 2.9 | 2.6 | 2.9 | · | 2.7 | 2.8 | 3.2 | · | 3.3 | · | · | · | · | |
| Earnings Yield | -0.19% | -2.5% | · | -4.4% | -6.9% | 3.4% | · | 7.0% | 5.5% | 3.7% | · | 3.4% | 2.3% | 0.90% | · | -0.44% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B |
| Utile netto | $-356M | $560M | $415M | $-224M | $-330M |
| EPS Diluito | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 690 filer · $9.8B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 143 (+46 vs trimestre precedente) | 56 (-21 vs trimestre precedente) | 220 (+20 vs trimestre precedente) | 190 (+12 vs trimestre precedente) | +4.4M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| FMR LLC | $846.470.147 | 3.512.762 | 8,60% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $731.636.247 | 3.036.213 | 7,43% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $657.763.761 | 2.729.650 | 6,68% | Azioni |
| Capital World Investors | $650.043.082 | 2.697.610 | 6,60% | Azioni |
| STATE STREET CORP | $481.895.662 | 1.999.816 | 4,89% | Azioni |
| FULLER & THALER ASSET MANAGEMENT, INC. | $394.839.917 | 1.638.544 | 4,01% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $390.196.222 | 1.619.274 | 3,96% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $297.928.728 | 1.236.065 | 3,03% | Azioni |
| AMERIPRISE FINANCIAL INC | $260.580.996 | 1.081.421 | 2,65% | Azioni |
| CITADEL ADVISORS LLC | $242.578.716 | 1.006.676 | 2,46% | Azioni |
| Swedbank AB | $233.208.837 | 967.792 | 2,37% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $184.072.164 | 763.880 | 1,87% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $165.478.678 | 686.719 | 1,68% | Azioni |
| NORGES BANK | $158.279.458 | 656.843 | 1,61% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $135.442.731 | 562.073 | 1,38% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $129.891.746 | 539.037 | 1,32% | Azioni |
| Allianz Asset Management GmbH | $122.925.785 | 510.129 | 1,25% | Azioni |
| GMT Capital Corp | $109.279.895 | 453.500 | 1,11% | Azioni |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $105.278.106 | 436.893 | 1,07% | Azioni |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $103.893.734 | 431.148 | 1,06% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $96.439.086 | 400.212 | 0,98% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $95.008.929 | 394.277 | 0,96% | Azioni |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $89.279.867 | 370.502 | 0,91% | Azioni |
| Sofinnova Investments, Inc. | $88.036.221 | 365.341 | 0,89% | Azioni |
| Polaris Capital Management, LLC | $79.270.937 | 328.966 | 0,81% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $77.695.234 | 322.427 | 0,79% | Azioni |
| Bank of New York Mellon Corp | $76.961.481 | 319.382 | 0,78% | Azioni |
| GOLDENTREE ASSET MANAGEMENT LP | $70.838.675 | 294.435 | 0,72% | Azioni |
| Qube Research & Technologies Ltd | $70.056.003 | 290.725 | 0,71% | Azioni |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $66.815.854 | 277.279 | 0,68% | Azioni |
| Quantinno Capital Management LP | $65.906.960 | 273.506 | 0,67% | Azioni |
| Boston Trust Walden Corp | $64.110.068 | 266.050 | 0,65% | Azioni |
| BANK OF AMERICA CORP /DE/ | $60.589.497 | 251.440 | 0,62% | Azioni |
| Tri Locum Partners LP | $53.427.868 | 221.720 | 0,54% | Azioni |
| Iron Triangle Partners LP | $49.668.900 | 292.170 | 0,50% | Azioni |
| ARGENT CAPITAL MANAGEMENT LLC | $48.211.350 | 200.072 | 0,49% | Azioni |
| GOLDMAN SACHS GROUP INC | $45.527.185 | 188.933 | 0,46% | Azioni |
| PERCEPTIVE ADVISORS LLC | $40.964.900 | 170.000 | 0,42% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $39.434.259 | 163.648 | 0,40% | Azioni |
| RHUMBLINE ADVISERS | $39.282.382 | 163.018 | 0,40% | Azioni |
| Holocene Advisors, LP | $38.794.001 | 160.991 | 0,39% | Azioni |
| Saturn V Capital Management LP | $38.781.230 | 160.938 | 0,39% | Azioni |
| PFM Health Sciences, LP | $38.740.265 | 160.768 | 0,39% | Azioni |
| Retirement Systems of Alabama | $38.473.993 | 159.663 | 0,39% | Azioni |
| Woodline Partners LP | $36.165.501 | 150.083 | 0,37% | Azioni |
| LOOMIS SAYLES & CO L P | $35.355.338 | 146.721 | 0,36% | Azioni |
| Pictet Asset Management Holding SA | $35.115.175 | 147.599 | 0,36% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $34.163.762 | 141.776 | 0,35% | Azioni |
| STIFEL FINANCIAL CORP | $33.583.066 | 139.365 | 0,34% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $33.026.625 | 137.057 | 0,34% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $32.383.478 | 134.388 | 0,33% | Azioni |
| California Public Employees Retirement System | $30.759.098 | 127.647 | 0,31% | Azioni |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $30.249.134 | 160.006 | 0,31% | Azioni |
| Robeco Institutional Asset Management B.V. | $28.340.967 | 117.612 | 0,29% | Azioni |
| Gotham Asset Management, LLC | $26.992.014 | 112.014 | 0,27% | Azioni |
| Aristotle Capital Management, LLC | $26.915.626 | 111.697 | 0,27% | Azioni |
| Swiss National Bank | $26.771.767 | 111.100 | 0,27% | Azioni |
| STOREBRAND ASSET MANAGEMENT AS | $26.309.828 | 109.183 | 0,27% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $25.928.372 | 107.600 | 0,26% | Azioni |
| PANAGORA ASSET MANAGEMENT INC | $25.286.187 | 104.935 | 0,26% | Azioni |
| BlackRock, Inc. | $23.889.284 | 99.138 | 0,24% | Azioni |
| Perpetual Ltd | $23.733.376 | 98.491 | 0,24% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $23.658.917 | 98.182 | 0,24% | Azioni |
| MORGAN STANLEY | $23.519.795 | 97.604 | 0,24% | Azioni |
| Man Group plc | $23.299.389 | 96.690 | 0,24% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22.868.053 | 94.900 | 0,23% | Opzione Put |
| ENVESTNET ASSET MANAGEMENT INC | $22.061.835 | 91.554 | 0,22% | Azioni |
| Rhenman & Partners Asset Management AB | $21.070.417 | 87.440 | 0,21% | Azioni |
| Aberdeen Group plc | $20.146.538 | 83.606 | 0,20% | Azioni |
| Amundi | $19.114.464 | 79.323 | 0,19% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.916.145 | 78.500 | 0,19% | Opzione Call |
| Schonfeld Strategic Advisors LLC | $18.620.232 | 77.272 | 0,19% | Azioni |
| FIRST TRUST ADVISORS LP | $18.149.860 | 75.320 | 0,18% | Azioni |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $17.765.513 | 73.725 | 0,18% | Azioni |
| LAZARD ASSET MANAGEMENT LLC | $16.768.620 | 69.588 | 0,17% | Azioni |
| Longaeva Partners L.P. | $16.576.808 | 68.792 | 0,17% | Azioni |
| Simplify Asset Management Inc. | $16.520.903 | 68.560 | 0,17% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $16.497.448 | 87.265 | 0,17% | Azioni |
| Distillate Capital Partners LLC | $16.167.159 | 67.092 | 0,16% | Azioni |
| SEB Asset Management AB | $15.890.255 | 65.943 | 0,16% | Azioni |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $15.380.484 | 64.700 | 0,16% | Azioni |
| SEI INVESTMENTS CO | $14.931.224 | 61.963 | 0,15% | Azioni |
| Illinois Municipal Retirement Fund | $14.911.947 | 61.883 | 0,15% | Azioni |
| Tweedy, Browne Co LLC | $14.494.105 | 60.149 | 0,15% | Azioni |
| MARTINGALE ASSET MANAGEMENT L P | $14.335.788 | 59.492 | 0,15% | Azioni |
| DeepCurrents Investment Group LLC | $14.132.168 | 58.647 | 0,14% | Azioni |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $13.348.774 | 55.396 | 0,14% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $12.952.138 | 53.750 | 0,13% | Azioni |
| ExodusPoint Capital Management, LP | $12.819.845 | 53.201 | 0,13% | Azioni |
| Squarepoint Ops LLC | $12.807.074 | 53.148 | 0,13% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12.034.356 | 63.657 | 0,12% | Azioni |
| ALGERT GLOBAL LLC | $11.749.697 | 48.760 | 0,12% | Azioni |
| CASTLEARK MANAGEMENT LLC | $11.306.312 | 46.920 | 0,11% | Azioni |
| CITADEL ADVISORS LLC | $11.253.299 | 46.700 | 0,11% | Opzione Call |
| RENAISSANCE GROUP LLC | $11.221.601 | 46.568 | 0,11% | Azioni |
| Nuveen, LLC | $11.184.623 | 46.415 | 0,11% | Azioni |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $10.859.795 | 45.067 | 0,11% | Azioni |
| Foundry Partners, LLC | $10.730.160 | 86.429 | 0,11% | Azioni |
| Legal & General Group Plc | $10.402.916 | 43.171 | 0,11% | Azioni |
| DEAN INVESTMENT ASSOCIATES, LLC | $10.273.274 | 42.633 | 0,10% | Azioni |
Insider aziendali 50 insider · 4 dirigenti · 4 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Renee D Gala | President & CEO | 30 Giugno 2026 F | 147.361 | 0 | 0 | $0 |
| Philip L Johnson | EVP & Chief Financial Officer | 30 Giugno 2026 F | 56.431 | 0 | 0 | $0 |
| Neena M Patil | EVP & Chief Legal Officer | 30 Giugno 2026 F | 48.871 | 0 | 2 | $-560.664 |
| Robert Iannone | EVP, Global Head of R&D & CMO | 30 Giugno 2026 F | 85.107 | 0 | 0 | $0 |
| Bryan C Cressey | Direttore | 09 Marzo 2012 S | 27.631 | 0 | 0 | $0 |
| Zilkha M Nathaniel | Direttore | 10 Marzo 2011 A | — | 0 | 0 | $0 |
| Alexander E Albert | Direttore | 15 Agosto 2008 A | — | 0 | 0 | $0 |
| Patel Jaimin | Direttore | 15 Agosto 2007 A | — | 0 | 0 | $0 |
| Patrick Kennedy | — | 05 Agosto 2026 A | 8.307 | 0 | 0 | $0 |
| Samantha Pearce | — | 05 Agosto 2026 F | 47.131 | 0 | 1 | $-1.625.977 |
| Mark Douglas Smith | — | 05 Agosto 2026 A | 11.285 | 0 | 1 | $-266.746 |
| Jennifer E. Cook | — | 05 Agosto 2026 A | 12.442 | 0 | 0 | $0 |
| Laura Hamill | — | 05 Agosto 2026 A | 8.538 | 0 | 0 | $0 |
| Heather Ann Mcsharry | — | 05 Agosto 2026 A | 20.054 | 0 | 0 | $0 |
| Seamus Mulligan | — | 05 Agosto 2026 A | 1.184.633 | 0 | 0 | $0 |
| Rick E Winningham | — | 05 Agosto 2026 A | 11.172 | 0 | 2 | $-1.656.873 |
| Patrick G. Enright | — | 05 Agosto 2026 A | 22.984 | 0 | 0 | $0 |
| Bruce C Cozadd | — | 05 Agosto 2026 A | 362.287 | 0 | 20 | $-25.646.326 |
| Ted W Love | — | 05 Agosto 2026 A | 3.132 | 0 | 0 | $0 |
| Norbert G Riedel | — | 05 Agosto 2026 A | 8.629 | 0 | 1 | $-655.680 |
| Kenneth W O'Keefe | — | 02 Dicembre 2025 F | 25.811 | 0 | 0 | $0 |
| Daniel N Swisher JR | — | 03 Gennaio 2019 F | 16.512 | 0 | 0 | $0 |
| Suzanne Sawochka Hooper | — | 14 Dicembre 2018 M | 41.184 | 0 | 0 | $0 |
| Matthew P. Young | — | 23 Novembre 2018 S | 32.068 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | — | 13 Novembre 2018 S | 24.972 | 0 | 0 | $0 |
| Paul Treacy | — | 10 Agosto 2018 S | 17.458 | 0 | 0 | $0 |
| Elmar Schnee | — | 09 Agosto 2018 A | 6.094 | 0 | 0 | $0 |
| Peter Gray | — | 09 Agosto 2018 A | 8.182 | 0 | 0 | $0 |
| Catherine A. Sohn | — | 09 Agosto 2018 A | 7.654 | 0 | 0 | $0 |
| Paul L Berns | — | 09 Agosto 2018 A | 6.772 | 0 | 0 | $0 |
| Karen J Wilson | — | 11 Maggio 2018 S | 15.757 | 0 | 0 | $0 |
| Karen L. Smith | — | 05 Marzo 2018 F | 28.474 | 0 | 0 | $0 |
| Iain Mcgill | — | 05 Marzo 2018 F | 22.048 | 0 | 0 | $0 |
| Russell J. Cox | — | 06 Marzo 2017 F | 52.795 | 0 | 0 | $0 |
| Jeffrey K Tobias | — | 05 Marzo 2015 F | 38.484 | 0 | 0 | $0 |
| Fintan Keegan | — | 08 Luglio 2014 M | 31.750 | 0 | 0 | $0 |
| Kathryn E Falberg | — | 05 Marzo 2014 F | 133.387 | 0 | 0 | $0 |
| James C Momtazee | — | 13 Agosto 2013 S | 17.315 | 0 | 0 | $0 |
| Carol A Gamble | — | 09 Marzo 2012 S | 32.213 | 0 | 0 | $0 |
| Alan Sebulsky | — | 09 Marzo 2012 S | 54.355 | 0 | 0 | $0 |
| Samuel D Colella | — | 11 Gennaio 2012 M | 38.347 | 0 | 0 | $0 |
| Michael W Michelson | — | 11 Gennaio 2012 M | 13.885 | 0 | 0 | $0 |
| Mark G. Eller | — | 13 Agosto 2011 M | 4.151 | 0 | 0 | $0 |
| Michael A. Desjardin | — | 13 Agosto 2011 M | 14.574 | 0 | 0 | $0 |
| Janne Lt Wissel | — | 31 Maggio 2011 J | 48.544 | 0 | 0 | $0 |
| Joan Colligan | — | 30 Novembre 2010 J | 14.424 | 0 | 0 | $0 |
| Robert M Myers | — | 30 Novembre 2010 J | 156.898 | 0 | 0 | $0 |
| James B Tananbaum | — | 25 Agosto 2010 A | 21.366 | 0 | 0 | $0 |
| Samuel R Saks | — | 21 Gennaio 2009 A | 358.868 | 0 | 0 | $0 |
| Matthew K Fust | — | 28 Novembre 2008 J | 58.948 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 6 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals Public Limited Company, Jazz Financing I Limited, Jazz Investments II Limited, Jazz Pharmaceuticals Italy S.p.A. ×4 depositi | 20 Giugno 2014 | — | Deposito iniziale | — | SEC |
| KKR JP LLC, KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, KKR JP III LLC, KKR Partners III, L.P., KKR III GP LLC, Henry R. Kravis, George R. Roberts ×3 depositi | 12 Marzo 2013 | — | Deposito iniziale | — | SEC |
| Longitude Capital Partners, LLC, Longitude Venture Partners, L.P., Longitude Capital Associates, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×3 depositi | 14 Marzo 2012 | — | Deposito iniziale | — | SEC |
| Longitude Capital Partners, LLC (2), Longitude Venture Partners, L.P. (2), Longitude Capital Associates, L.P. (2), Patrick G. Enright (2), Juliet Tammenoms Bakker (2) ×3 depositi | 30 Settembre 2011 | — | Deposito iniziale | — | SEC |
| Azur Pharma Limited | 28 Settembre 2011 | — | Deposito iniziale | — | SEC |
| Jazz Pharmaceuticals, Inc., KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Partners III, L.P., KKR III GP LLC, KKR JP LLC, KKR JP III LLC | 28 Aprile 2005 | — | Deposito iniziale | M&A / vendita | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 72 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IHE · iShares Trust | 3,55% | 224.123 SH | 08 Agosto 2026 | Giornaliero |
| PJP · Invesco Exchange-Traded Fund Trust | 2,75% | 54.246 SH | 08 Agosto 2026 | Giornaliero |
| PTH · Invesco Exchange-Traded Fund Trust | 1,88% | 18.101 SH | 08 Agosto 2026 | Giornaliero |
| PILL · Direxion Shares ETF Trust | 1,47% | 931 NS | 30 Aprile 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,10% | 3.412 SH | 08 Agosto 2026 | Giornaliero |
| RFG · Invesco Exchange-Traded Fund Trust | 1,01% | 14.167 SH | 08 Agosto 2026 | Giornaliero |
| IJK · iShares Trust | 0,86% | 367.117 SH | 08 Agosto 2026 | Giornaliero |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,79% | 61.910 SH | 08 Agosto 2026 | Giornaliero |
| PDP · Invesco Exchange-Traded Fund Trust | 0,64% | 37.430 SH | 08 Agosto 2026 | Giornaliero |
| XJH · iShares Trust | 0,51% | 8.479 SH | 08 Agosto 2026 | Giornaliero |
| ISCV · iShares Trust | 0,50% | 13.756 SH | 08 Agosto 2026 | Giornaliero |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,50% | 14.803 NS | 30 Aprile 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0,49% | 12.809 NS | 31 Maggio 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,48% | 8.322 SH | 08 Agosto 2026 | Giornaliero |
| IJH · iShares Trust | 0,44% | 2.164.793 SH | 08 Agosto 2026 | Giornaliero |
| SMMV · iShares Trust | 0,41% | 4.673 SH | 08 Agosto 2026 | Giornaliero |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,41% | 101.353 SH | 08 Agosto 2026 | Giornaliero |
| VFVA · VANGUARD WELLINGTON FUND | 0,32% | 11.363 SH | 08 Agosto 2026 | Giornaliero |
| VBR · VANGUARD INDEX FUNDS | 0,31% | 867.777 SH | 08 Agosto 2026 | Giornaliero |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,28% | 154.718 NS | 31 Maggio 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,28% | 8.083 SH | 08 Agosto 2026 | Giornaliero |
| IYH · iShares Trust | 0,25% | 35.721 SH | 08 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | 0,25% | 2.794 SH | 08 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,25% | 169.973 NS | 30 Aprile 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,24% | 1.006 NS | 30 Aprile 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,24% | 19.561 SH | 08 Agosto 2026 | Giornaliero |
| NUSC · Nushares ETF Trust | 0,23% | 14.796 NS | 30 Aprile 2026 | N-PORT |
| ESML · iShares Trust | 0,23% | 25.562 SH | 08 Agosto 2026 | Giornaliero |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,20% | 3.508 NS | 31 Maggio 2026 | N-PORT |
| SMMD · iShares Trust | 0,20% | 29.882 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,20% | 166.548 SH | 08 Agosto 2026 | Giornaliero |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,20% | 10.307 SH | 08 Agosto 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,17% | 719.903 SH | 08 Agosto 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,17% | 1.366.973 SH | 08 Agosto 2026 | Giornaliero |
| DFAT · Dimensional ETF Trust | 0,17% | 113.983 NS | 30 Aprile 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,16% | 59.597 NS | 30 Aprile 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,15% | 1.679 NS | 31 Maggio 2026 | N-PORT |
| IWS · iShares Trust | 0,15% | 89.654 SH | 08 Agosto 2026 | Giornaliero |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,14% | 59 NS | 31 Maggio 2026 | N-PORT |
| WSML · iShares Trust | 0,13% | 3.473 SH | 08 Agosto 2026 | Giornaliero |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,13% | 2.492 NS | 31 Maggio 2026 | N-PORT |
| IWR · iShares Trust | 0,11% | 243.081 SH | 08 Agosto 2026 | Giornaliero |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 3.276 SH | 08 Agosto 2026 | Giornaliero |
| XT · iShares Trust | 0,09% | 13.696 SH | 08 Agosto 2026 | Giornaliero |
| AVLC · AMERICAN CENTURY ETF TRUST | 0,08% | 4.239 NS | 31 Maggio 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,08% | 42.911 NS | 31 Maggio 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,07% | 2.294 NS | 31 Maggio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,07% | 147.813 NS | 30 Aprile 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,06% | 45.962 NS | 30 Aprile 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,05% | 7.081 NS | 30 Aprile 2026 | N-PORT |